Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George J Netto

Showing results (1-10 of 315) with videos related to

Pageof 32
Sort By:
The Journal of Urology|November 16, 2010
Tumor volume threshold of insignificant prostate cancer--was Dr. Stamey right all along?George J Netto
Archives of Pathology & Laboratory Medicine|April 30, 2011
Molecular diagnostics in urologic malignancies: a work in progressGeorge J Netto
Advances in Anatomic Pathology|December 10, 2019
The Ever Changing Landscape of Anatomic Pathology PracticeGeorge J Netto
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 4, 2020
EditorialGeorge J Netto
Advances in Anatomic Pathology|April 12, 2013
Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"?George J Netto
Surgical Pathology Clinics|February 4, 2016
Molecular Pathology of Bladder CancerGeorge J Netto
Urology|November 4, 2009
Editorial commentGeorge J Netto
Nature Reviews. Urology|December 14, 2011
Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?George J Netto
Histopathology|October 20, 2010
TMPRSS2-ERG fusion as a marker of prostatic lineage in small-cell carcinomaGeorge J Netto
Lancet (London, England)|March 9, 2016
Role for anti-PD-L1 immune checkpoint inhibitor in advanced urothelial carcinomaGeorge J Netto
Pageof 32

Showing results (1-10 of 315) with videos related to

Sort By:
Pageof 32
The Journal of Urology|November 16, 2010
Tumor volume threshold of insignificant prostate cancer--was Dr. Stamey right all along?George J Netto
Archives of Pathology & Laboratory Medicine|April 30, 2011
Molecular diagnostics in urologic malignancies: a work in progressGeorge J Netto
Advances in Anatomic Pathology|December 10, 2019
The Ever Changing Landscape of Anatomic Pathology PracticeGeorge J Netto
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 4, 2020
EditorialGeorge J Netto
Advances in Anatomic Pathology|April 12, 2013
Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"?George J Netto
Surgical Pathology Clinics|February 4, 2016
Molecular Pathology of Bladder CancerGeorge J Netto
Urology|November 4, 2009
Editorial commentGeorge J Netto
Nature Reviews. Urology|December 14, 2011
Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?George J Netto
Histopathology|October 20, 2010
TMPRSS2-ERG fusion as a marker of prostatic lineage in small-cell carcinomaGeorge J Netto
Lancet (London, England)|March 9, 2016
Role for anti-PD-L1 immune checkpoint inhibitor in advanced urothelial carcinomaGeorge J Netto
Pageof 32